Vaxcyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vaxcyte and other ETFs, options, and stocks.About PCVX
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology.
CEOGrant E. Pickering
CEOGrant E. Pickering
Employees507
Employees507
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2013
Founded2013
Employees507
Employees507
PCVX Key Statistics
Market cap9.59B
Market cap9.59B
Price-Earnings ratio-7.56
Price-Earnings ratio-7.56
Dividend yield—
Dividend yield—
Average volume1.01M
Average volume1.01M
High today$59.39
High today$59.39
Low today$57.83
Low today$57.83
Open price$58.72
Open price$58.72
Volume146.09K
Volume146.09K
52 Week high$65.00
52 Week high$65.00
52 Week low$29.51
52 Week low$29.51
Stock Snapshot
The current Vaxcyte(PCVX) stock price is $59.38, with a market capitalization of 9.59B. The stock trades at a price-to-earnings (P/E) ratio of -7.56.
As of 2026-08-11, Vaxcyte(PCVX) stock has fluctuated between $57.83 and $59.39. The current price stands at $59.38, placing the stock +2.7% above today's low and -0.0% off the high.
Vaxcyte(PCVX) shares are trading with a volume of 146.09K, against a daily average of 1.01M.
During the past year, Vaxcyte(PCVX) stock moved between $29.51 at its lowest and $65.00 at its peak.
During the past year, Vaxcyte(PCVX) stock moved between $29.51 at its lowest and $65.00 at its peak.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own PCVX. This list is generated using Robinhood data, and it’s not a recommendation.